Search by Drug Name or NDC

    NDC 50804-0316-08 Severe Cold and Cough Relief 650; 20; 10 mg/30mL; mg/30mL; mg/30mL Details

    Severe Cold and Cough Relief 650; 20; 10 mg/30mL; mg/30mL; mg/30mL

    Severe Cold and Cough Relief is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Good Sense (Geiss, Destin & Dunn, Inc.). The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 50804-0316
    Product ID 50804-316_3f972a81-2984-49f6-b3a5-488944034142
    Associated GPIs 43996903400910
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Severe Cold and Cough Relief
    Proprietary Name Suffix Daytime
    Non-Proprietary Name ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 650; 20; 10
    Active Ingredient Units mg/30mL; mg/30mL; mg/30mL
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Good Sense (Geiss, Destin & Dunn, Inc.)
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 50804-0316-08 (50804031608)

    NDC Package Code 50804-316-08
    Billing NDC 50804031608
    Package 245 mL in 1 BOTTLE, PLASTIC (50804-316-08)
    Marketing Start Date 2016-07-31
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL d0b0c0a2-97f5-4967-87e4-df0f8be6bd0b Details

    Revised: 10/2022